16 filings
8-K
VOR
Vor Biopharma Inc
2 May 24
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
4:07pm
8-K
VOR
Vor Biopharma Inc
5 Jan 24
Other Events
5:03pm
8-K
VOR
Vor Biopharma Inc
2 Nov 23
Multiple Clinical and Preclinical Presentations at ASH 2023
9:10am
8-K
VOR
Vor Biopharma Inc
9 Jun 23
Regulation FD Disclosure
7:41am
8-K
VOR
Vor Biopharma Inc
26 May 23
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
d1p5xx r1
14 Apr 23
Departure of Directors or Certain Officers
4:01pm
8-K
8ksxi67u8ng16ik2
16 Feb 23
Regulation FD Disclosure
12:13pm
8-K
pls84fr 9la5hq8
23 Dec 22
Entry into a Material Definitive Agreement
4:07pm
8-K
md3h3
14 Dec 22
Termination of a Material Definitive Agreement
4:32pm
8-K
hp92xyuonht7q
7 Dec 22
Vor Bio Prices Underwritten Offering of Common Stock and Concurrent
4:59pm
8-K
ch4khqs88znk4863b9c
7 Dec 22
Regulation FD Disclosure
7:36am
8-K
8nwyv7l
29 Nov 22
Regulation FD Disclosure
10:25am
8-K
woom360l7mj
17 Jun 22
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
8iv6 lhomjj
14 Apr 22
Departure of Directors or Certain Officers
4:01pm
8-K
i7gob
17 Jun 21
Entry into a Material Definitive Agreement
8:13am
8-K
k6doz
9 Feb 21
Vor Biopharma Closes Over $200M Initial Public Offering, Including Full Exercise of Option to
4:21pm
- Prev
- 1
- Next